TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biologic Therapeutics Drugs Market Research Report 2022

Global Biologic Therapeutics Drugs Market Research Report 2022

  • Category:Life Sciences
  • Published on : 31 December 2022
  • Pages :96
  • Formats:
  • Report Code:SMR-7524904
OfferClick for best price

Best Price: $2320

Biologic Therapeutics Drugs Market Size, Share 2022


Market Analysis and Insights: Global Biologic Therapeutics Drugs Market

The global Biologic Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Therapeutics Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Therapeutics Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Therapeutics Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Therapeutics Drugs market.

Global Biologic Therapeutics Drugs Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Avian Cell Culture

Yeast

Bacteria

Insects Cell Culture

Transgenics

Segment by Application

Rheumatoid Arthritis

Anemia

Cancer

Diabetes

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Pfizer

AstraZeneca

Novartis

Merck

Smith Medical

GlaxoSmithKline

Concord Biotech

Aurobindo Pharma

H. Lundbeck

Retractable Technologies

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biologic Therapeutics Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biologic Therapeutics Drugs, with price, sales, revenue, and global market share of Biologic Therapeutics Drugs from 2019 to 2022.

Chapter 3, the Biologic Therapeutics Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biologic Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biologic Therapeutics Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics Drugs.

Chapter 13, 14, and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biologic Therapeutics Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Biologic Therapeutics Drugs Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 96 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Biologic Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Biologic Therapeutics Drugs Segment by Type
1.2.1 Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Biologic Therapeutics Drugs Segment by Application
1.3.1 Global Biologic Therapeutics Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Biologic Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Biologic Therapeutics Drugs Sales 2017-2028
1.4.3 Biologic Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biologic Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biologic Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Biologic Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Biologic Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologic Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Biologic Therapeutics Drugs Sales by Country
3.3.2 North America Biologic Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Biologic Therapeutics Drugs Sales by Country
3.4.2 Europe Biologic Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Biologic Therapeutics Drugs Sales by Country
3.6.2 Latin America Biologic Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biologic Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Biologic Therapeutics Drugs Price by Type (2017-2022)
5 Global Biologic Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2022)
5.2 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Biologic Therapeutics Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis Biologic Therapeutics Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Biologic Therapeutics Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Smith Medical
6.5.1 Smith Medical Corporation Information
6.5.2 Smith Medical Description and Business Overview
6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
6.5.5 Smith Medical Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Concord Biotech
6.6.1 Concord Biotech Corporation Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
6.7.5 Concord Biotech Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 H. Lundbeck
6.9.1 H. Lundbeck Corporation Information
6.9.2 H. Lundbeck Description and Business Overview
6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
6.9.5 H. Lundbeck Recent Developments/Updates
6.10 Retractable Technologies
6.10.1 Retractable Technologies Corporation Information
6.10.2 Retractable Technologies Description and Business Overview
6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
6.10.5 Retractable Technologies Recent Developments/Updates
7 Biologic Therapeutics Drugs Manufacturing Cost Analysis
7.1 Biologic Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biologic Therapeutics Drugs
7.4 Biologic Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biologic Therapeutics Drugs Distributors List
8.3 Biologic Therapeutics Drugs Customers
9 Biologic Therapeutics Drugs Market Dynamics
9.1 Biologic Therapeutics Drugs Industry Trends
9.2 Biologic Therapeutics Drugs Market Drivers
9.3 Biologic Therapeutics Drugs Market Challenges
9.4 Biologic Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Biologic Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Type (2023-2028)
10.2 Biologic Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Application (2023-2028)
10.3 Biologic Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Biologic Therapeutics Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Biologic Therapeutics Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Biologic Therapeutics Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Biologic Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Biologic Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Biologic Therapeutics Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biologic Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Biologic Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Biologic Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Biologic Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Biologic Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 43. Global Biologic Therapeutics Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Biologic Therapeutics Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Biologic Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Biologic Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 48. Global Biologic Therapeutics Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Biologic Therapeutics Drugs Product
Table 53. Pfizer Recent Developments/Updates
Table 54. AstraZeneca Corporation Information
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. AstraZeneca Biologic Therapeutics Drugs Product
Table 58. AstraZeneca Recent Developments/Updates
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Novartis Biologic Therapeutics Drugs Product
Table 63. Novartis Recent Developments/Updates
Table 64. Merck Corporation Information
Table 65. Merck Description and Business Overview
Table 66. Merck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Merck Biologic Therapeutics Drugs Product
Table 68. Merck Recent Developments/Updates
Table 69. Smith Medical Corporation Information
Table 70. Smith Medical Description and Business Overview
Table 71. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Smith Medical Biologic Therapeutics Drugs Product
Table 73. Smith Medical Recent Developments/Updates
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. GlaxoSmithKline Biologic Therapeutics Drugs Product
Table 78. GlaxoSmithKline Recent Developments/Updates
Table 79. Concord Biotech Corporation Information
Table 80. Concord Biotech Description and Business Overview
Table 81. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Concord Biotech Biologic Therapeutics Drugs Product
Table 83. Concord Biotech Recent Developments/Updates
Table 84. Aurobindo Pharma Corporation Information
Table 85. Aurobindo Pharma Description and Business Overview
Table 86. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Aurobindo Pharma Biologic Therapeutics Drugs Product
Table 88. Aurobindo Pharma Recent Developments/Updates
Table 89. H. Lundbeck Corporation Information
Table 90. H. Lundbeck Description and Business Overview
Table 91. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. H. Lundbeck Biologic Therapeutics Drugs Product
Table 93. H. Lundbeck Recent Developments/Updates
Table 94. Retractable Technologies Corporation Information
Table 95. Retractable Technologies Description and Business Overview
Table 96. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Retractable Technologies Biologic Therapeutics Drugs Product
Table 98. Retractable Technologies Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Biologic Therapeutics Drugs Distributors List
Table 102. Biologic Therapeutics Drugs Customers List
Table 103. Biologic Therapeutics Drugs Market Trends
Table 104. Biologic Therapeutics Drugs Market Drivers
Table 105. Biologic Therapeutics Drugs Market Challenges
Table 106. Biologic Therapeutics Drugs Market Restraints
Table 107. Global Biologic Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Biologic Therapeutics Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Biologic Therapeutics Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Biologic Therapeutics Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Biologic Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Biologic Therapeutics Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biologic Therapeutics Drugs
Figure 2. Global Biologic Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Avian Cell Culture Product Picture
Figure 4. Yeast Product Picture
Figure 5. Bacteria Product Picture
Figure 6. Insects Cell Culture Product Picture
Figure 7. Transgenics Product Picture
Figure 8. Global Biologic Therapeutics Drugs Market Share by Application in 2021 & 2028
Figure 9. Rheumatoid Arthritis
Figure 10. Anemia
Figure 11. Cancer
Figure 12. Diabetes
Figure 13. Others
Figure 14. Global Biologic Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Biologic Therapeutics Drugs Market Size (2017-2028) & (US$ Million)
Figure 16. Global Biologic Therapeutics Drugs Sales (2017-2028) & (K Units)
Figure 17. Biologic Therapeutics Drugs Sales Share by Manufacturers in 2021
Figure 18. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Biologic Therapeutics Drugs Players: Market Share by Revenue in 2021
Figure 20. Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Biologic Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 22. Global Biologic Therapeutics Drugs Sales Market Share by Region in 2021
Figure 23. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Figure 24. Global Biologic Therapeutics Drugs Revenue Market Share by Region in 2021
Figure 25. U.S. Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Taiwan Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Philippines Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Vietnam Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. U.A.E Biologic Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of Biologic Therapeutics Drugs by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of Biologic Therapeutics Drugs
Figure 51. Manufacturing Process Analysis of Biologic Therapeutics Drugs
Figure 52. Biologic Therapeutics Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount